Additional file 2 of Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer

Authors :: Kaminska, Kamila
Akrap, Nina
Staaf, Johan
Alves, Carla L.
Ehinger, Anna
Ebbesson, Anna
Hedenfalk, Ingrid
Beumers, Lukas
Veerla, Srinivas
Harbst, Katja
Ehmsen, Sidse
Borgquist, Signe
Borg, Åke
Pérez-Fidalgo, Alejandro
Ditzel, Henrik J.
Bosch, Ana
Honeth, Gabriella
Publication Year :: 2021
Publisher :: figshare, 2021.
Abstract: Additional file 2. Table showing patient characteristics for patient samples pre and post fulvestrant treatment.

Full Text Access

Tools